Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

NAVA-Chiron Behring vaccine distribution agreement signed

Dec. 12, 1996

LG Chemical describes novel vaccine adjuvant formulation

Dec. 11, 1996

Oral influenza vaccine from Cortecs enters clinic

Dec. 4, 1996

AADA filed for generic ciclosporin

Dec. 3, 1996

Vasogen autocellular response therapy appears effective in RA

Nov. 29, 1996

Partners sought for 3DP MHC blockers

Nov. 29, 1996

Disappointing results reported for genital herpes vaccine

Nov. 28, 1996

Vaccine against H. influenzae offered for licensing

Nov. 26, 1996

NABI to reformulate StaphVAX

Nov. 26, 1996

GBS vaccine proven safe and immunogenic

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...